Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Accumulated Expenses (2021 - 2025)

Historic Accumulated Expenses for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $11.1 million.

  • Biote's Accumulated Expenses rose 3534.51% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year increase of 3534.51%. This contributed to the annual value of $11.3 million for FY2024, which is 3290.57% up from last year.
  • Per Biote's latest filing, its Accumulated Expenses stood at $11.1 million for Q3 2025, which was up 3534.51% from $9.0 million recorded in Q2 2025.
  • Over the past 5 years, Biote's Accumulated Expenses peaked at $16.3 million during Q2 2022, and registered a low of $4000.0 during Q3 2021.
  • Moreover, its 5-year median value for Accumulated Expenses was $7.5 million (2024), whereas its average is $7.4 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 14287500.0% in 2022, then plummeted by 6664.62% in 2023.
  • Over the past 5 years, Biote's Accumulated Expenses (Quarter) stood at $6.0 million in 2021, then increased by 4.38% to $6.3 million in 2022, then skyrocketed by 35.43% to $8.5 million in 2023, then surged by 32.91% to $11.3 million in 2024, then fell by 1.9% to $11.1 million in 2025.
  • Its Accumulated Expenses was $11.1 million in Q3 2025, compared to $9.0 million in Q2 2025 and $10.2 million in Q1 2025.